RxDoctor Payments Data

Gary Curran, MD

Family Medicine · Arden, NCNPI 1346225232

Payments from drug & device makers

$561in general payments, 2019–2025

Across 22 payments — averaging $25.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$191
  • AbbVie$53
  • Baxter Healthcare$50
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$40
  • AstraZeneca$36
  • Abbott$32
  • plus $158 from 8 others

What the payments were for

  • Food & beverage$561100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$561 in reported general payments places this provider in the 60th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$73,242
Medicare patients
165
Services billed
998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide64$81,013
EliquisApixaban83$61,169
GenvoyaElviteg/Cob/Emtri/Tenof Alafen12$45,427
XareltoRivaroxaban30$36,446
JanuviaSitagliptin Phosphate19$25,513
JardianceEmpagliflozin11$18,673
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,873
MultaqDronedarone Hcl11$8,830
ArexvyRsvpref3 Antigen/As01e/Pf14$4,375
ShingrixVaricella-Zoster Ge/As01b/Pf18$3,913
Estradiol23$3,775
LantusInsulin Glargine,hum.Rec.Anlog18$3,703
Metoprolol Succinate241$3,360
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen128$2,719
Levothyroxine Sodium241$2,697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$191$81,01364 claims
GSKTrelegy Ellipta, Arexvy, Shingrix$17$19,16049 claims
AbbVieSynthroid$53$2,10219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Arden

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →